Bandaram Pharma Packtech share price
BSE: 524602Healthcare ServicesSmall Cap
Last close ₹18.21down ₹0.79 (4.16%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹19.00.
52-week range of traded prices to 23 Oct 2026
₹17.25Low, 20 Aug 2026₹49.70High, 2 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹33 Cr3,419th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 5.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.76
- Volume, BSEVolume. Shares traded on the last trading day.
- 930
Results
Standalone, as consolidated accounts are on record for only 4 of the last ten years; ₹ crore, the charts by years to March, the table by quarter. No standalone results on record for the years to Mar 2019, Mar 2020 and Mar 2021.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 13 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹2.99 Crdown 63.58%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹0.36 CrQuarter to Mar 2026: −₹0.33 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- −12.0%
Revenue by year
Peak revenue ₹15 Cr, year to Mar 2024
Net profit by year, a loss in red
- Net profit
- Loss
A loss in the year to Mar 2026, −₹1.16 CrA loss in 4 of the 7 years with results on record
| ₹ crore | Sep 2024Filed 14 Nov | Dec 2024Filed 15 Feb | Mar 2025Filed 13 Jun | Jun 2025Filed 14 Aug | Sep 2025Filed 13 Nov | Dec 2025Filed 13 Feb | Mar 2026Filed 30 May | Jun 2026Filed 13 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.17 | 2.63 | 3.71 | 0.76 | 0.33 | 1.68 | 8.20 | 2.99 |
| Net profit | 0.33 | 0.01 | 0.04 | −0.27 | −0.35 | −0.21 | −0.33 | −0.36 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 10.4% | 0.6% | 1.2% | −35.5% | −105.5% | −12.6% | −4.0% | −12.0% |
Standalone. The last eight quarters. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, Paper and Packaging, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: a quarter's profit for shareholders does not agree with its own earnings per share.PE ratio and valuation history
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 3% of 661 trading days over the last 3 years.
LowestHighest
Its median0.30%Industry median0.38%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −49.3% | – | – | 0.0% |
Longer windows are left empty: a corporate action or price step on 2023-07-03 that cannot be sized sits inside this window. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Peers and competitors
Healthcare Service Provider, 36 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Bandaram Pharma Packtech in market cap.
Bandaram Pharma Packtech is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Aspira Pathlab & DiagnosticsASPIRA | 130 | – | 10.6 | 130.8 | +14.6% | −117.7% | −3.7% | −4.4% | 0.00% |
 Modern Diagnostic & Research CentreMDRC | 91 | 17.2 | 1.5 | – | – | – | 9.0% | – | 0.00% |
 Invicta DiagnosticINVICTA | 76 | 15.5 | 1.5 | 5.9 | – | – | 9.8% | 12.2% | 0.00% |
 N.G.IndustriesNGIND | 34 | 17.5 | 1.0 | 18.0 | +2.2% | −74.1% | 5.3% | 3.7% | 3.48% |
 Samsrita LabsSAMSRITA | 31 | – | 2.6 | – | – | – | – | −65.3% | 0.00% |
 Deccan Health CareDECCAN | 29 | 11.3 | 0.3 | 5.9 | −0.4% | +145.9% | 2.3% | 3.3% | 0.00% |
 Chennai Meenakshi Multispeciality HospitalCMMHOSP | 27 | – | – | 59.1 | +6.5% | – | – | −6.7% | 0.00% |
 Sharma East India Hospitals and ResSHARMEH | 26 | 21.9 | 1.9 | 9.2 | +14.1% | −9.9% | 9.0% | 9.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.Highest ₹0.10 a share, years to Mar 2023, Mar 2024 and Mar 2025.
| Ex-date | Type | Per share |
|---|---|---|
| 22 Sep 2025 | Final | ₹0.10 |
| 20 Sep 2024 | Final | ₹0.10 |
| 22 Sep 2023 | Final | ₹0.10 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
30 Sep · Board meeting
28 Sep · Board meeting
Meeting on 30 Sep 2026: amalgamation and scheme of arrangement24 Sep · Meeting
Bandaram Pharma Packtech share price by year
Each calendar year to 2025.Bandaram Pharma Packtech share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 29.77 | −34.8% | 50.00 | 23.33 |
| 2024 | 45.67 | +48.8% | 60.14 | 28.81 |
| 2023 | 30.69 | – | 30.69 | 25.26 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2023 is from its first session, 3 Jul 2023. The 2023 close is its last trade, on 18 Dec 2023.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 19.35 | 19.35 | 17.25 | 18.21 | 18.05 | 930 |
| 22 Oct 2026 | 19.60 | 19.60 | 19.00 | 19.00 | – | 68 |
| 21 Oct 2026 | 19.07 | 19.59 | 18.36 | 19.24 | 19.24 | 177 |
| 19 Oct 2026 | 19.05 | 19.05 | 19.05 | 19.05 | 19.05 | 1 |
| 16 Oct 2026 | 18.61 | 19.47 | 18.60 | 18.60 | 18.60 | 12,198 |
| 15 Oct 2026 | 19.50 | 19.50 | 18.52 | 18.52 | 19.48 | 5,402 |
| 14 Oct 2026 | 18.50 | 19.10 | 17.75 | 19.10 | 18.46 | 276 |
| 13 Oct 2026 | 18.60 | 18.60 | 17.85 | 18.55 | 18.27 | 451 |
| 12 Oct 2026 | 18.40 | 18.40 | 18.09 | 18.30 | 18.29 | 369 |
| 9 Oct 2026 | 17.51 | 18.59 | 17.51 | 18.59 | – | 27 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Rights issue and open offer history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 3 Jul 2023 | Price move | – | A corporate action went ex within three days of this move (Right Issue of Equity Shares, ex-date 30 Jun 2023), and its terms do not account for the move. Earlier prices are not shown. |
| 30 Jun 2023 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
| 18 Nov 2022 | Price move | – | This is the share's first trade after a corporate action (Resolution Plan -Suspension, ex-date 16 Mar 2022), and the action's terms do not account for the move. Not adjusted for. |
| 27 May 2016 | Price move | – | This is the share's first trade after a corporate action (Reduction of Capital, ex-date 3 Dec 2015), and the action's terms do not account for the move. Earlier prices are not shown. |
Where an event has no factor that can be worked out, the chart leaves out the closes before it. Any other event is noted and not adjusted for.
Company details
- Legal name
- BANDARAM PHARMA PACKTECH LIMITED
- BSE code
- 524602
- ISIN
- INE875N01036
- Industry
- Healthcare Services
- Listed
- Aug 1994
- Face value
- ₹10
- CIN
- L93090KA1993PLC159827
- Corporate identity number, the registrar of companies' code for it